[Objective]To summarize the traditional Chinese medicine(TCM)syndrome differentiation of"Zhangyitie Internal Medicine"to treat arthralgia disease.[Methods]By following patients and learning,collecting,sorting out and analyzing typical medical cases,consulting relevant ancient books and literature of TCM,comparing with what the main inheritors of"Zhangyitie Internal Medicine",master of Chinese medicine LI Jiren and Professor LI Yan talked about in the clinical treatment of syndrome,summarizing the thought and experience of syndrome differentiation of"Zhangyitie Internal Medicine"in the treatment of arthralgia disease from three aspects:etiology and pathogenesis,innovative new safety theory and clinical treatment,and adding two medical cases to prove it.[Results]Xin'an"Zhangyitie Internal Medicine"innovated Xin'an medical theory,established the"balance of cold and heat,consolidating basis and cultivating primordial Qi"theory and"cold and heat three phases"therapy to treat arthralgia disease,focusing on regulating cold and heat in clinic,consolidating basis and cultivating primordial Qi,harmonizing Qi and blood,resolving phlegm and dispersing blood stasis.In case one,the patient with repeated joint pain,and a long course of the disease was diagnosed with phlegm-stasis mutual obstruction type arthralgia disease,Professor LI Yan used self-created"Yishen Qingluo Huoxui Formula"plus Wutou Decoction to resolve phlegm and disperse blood stasis.The patient was overworked in the second case with felt dampness,multi-joint pain,swelling,adverse activity,local heat sensation and spirit fatigue,Professor LI Yan differentiated the patient as internal obstruction of dampness-heat and deficiency of Qi and blood type arthralgia disease and treated with clearing heat and detoxifying,invigorating Qi and activating blood to regulate cold and heat.[Conclusion]Xin'an"Zhangyitie Internal medicine"has formed its unique clinical characteristics in the treatment of arthralgia disease practice,with flexible syndrome differentiation,very effective,is an important branch of Xin'an medicine,it expands new ideas for TCM treatment of arthralgia disease,worthy of reference.

Objective:To summarize the surgical treatment experience of extended thymectomy for myasthenia gravis(MG), and to explore the surgical treatment of MG.Methods:Retrospectively analyzed the clinical data of 527 MG patients undergoing extended thymectomy in our hospital from June 1996 to October 2017, including 242 males and 285 females, aged 5 to 77 years, with a mean age of(52.6±13.7) years old. The course of illness was 12 days to 18 years. There were 22 cases of hyperthyroidism, 7 cases of pure red blood cell aplastic anemia, 1 case each of hypothyroidism, irritable bowel disease, rheumatoid arthritis, ankylosing spondylitis and thrombocytopenia syndrome. There were 272 cases of MG in Osserman Ⅰ, 72 cases inⅡa, 78 cases inⅡb, 81 cases in Ⅲ, and 24 cases in Ⅳ, respectively. The muscle fatigue test and neostigmine test of all patients were positive, and the diagnosis was confirmed by chest CT examination. Meanwhile, summarize the perioperative data and postoperative follow-up.Results:3 cases died during the postoperative period, all of which were thymoma with MG, including 2 cases of Osserman Ⅲ MG and 1 case of Ⅳ MG; 15 cases of postoperative myasthenia crisis, including 2 OssermanⅡb cases, 11 Osserman Ⅲ cases and 2 Osserman Ⅳ cases, also including 7 cases of tracheotomy; 70 cases of plasma exchange, of whom 2 cases of hypotonic syndrome and 2 cases of lower extremity venous thrombosis. The postoperative pathological types were followed by thymic hyperplasia 293 cases(55.60%), thymoma 207 cases(39.28%), thymic cyst 24 cases(4.55%) and thymic atrophy 3 cases(0.57%) in descending order. 378 cases were followed up with an average follow-up of(85.9±58.5)months; MG with complete remission, partial remission, no change and deterioration accounted for 135(35.71%), 192(50.79%), 41(10.85%) and 10(2.65%)cases, respectively. Complete remission rate ranked as Osserman typeⅠ>Ⅱa>Ⅳ>Ⅱb>Ⅲ, the deterioration rate from high to low was Osserman type Ⅲ>Ⅳ>Ⅰ. 18 OssermanⅠcases showed no effects, whose preoperative course of disease> 5-10 years; 1 OssermanⅠcase was worsening who initially was diagnosed with ophthalmic MG and underwent video-assisted thoracoscopic thymectomy. The left thymus lobe was left unresected and developed 6 years later. Another operation was performed to remove the left lobe thymus, confirming the compensatory hypertrophy of the left lobe thymus. Among the worsening patients, 6 died, all of them were thymoma with MG, including 5 cases of type Ⅲ and one case of type Ⅳ. The cause of death was omyasthenia crisis(3 cases), sudden respiratory arrest after 3 months of rapid stopping of brompistigmine(2 cases)and cholinergic crisis(1 case).Conclusion:Standardized extended thymectomy is an effective method for the treatment of MG. Earlier surgery for ocular muscle type MG can effectively reduce the risk of generalization. MG with Osserman Ⅱb or higher is prone to myasthenia crisis. Comprehensive treatments should be taken to reduce MG-related risks. Myasthenia crisis can occur repeatedly in severe patients in the long term after surgery, requiring regular medication and comprehensive MG treatments.

Objective To analyze the clinical and pathological characteristics of Alport syndrome in children. Methods Clinical and pathological information gathered from 62 patients during March 1989 to August 2012 was retrospectively analyzed. Results Four autosomal recessive Alport syndromes (AR-AS) and 58 X-linked Alport syndromes (XL-AS) were analyzed. Of the XL-AS, 47 were boys and 11 were girls. Most of patients induced by upper respiratory tract infections, and onset with hematuria and proteinuria. There was no signiifcant gender difference in family history, impaired renal tubular proteins, hypertension, im-paired renal function, hearing loss, ocular abnormalities or renal pathological changes under light microscopy. However, extensive lamination and split of glomerular basement membrane (GBM) dense layers were found in 83.0%male and 18.2%female patients (P=0.000) and the rest patients were presented with limited distribution of typical GBM changes. Proteinuria progressed signiif-cantly with age in XL-AS males (r=0.501, P=0.000). Five XL-AS patients developed to end stage renal disease (ESRD) between 11 to 16 years old. Conclusions XL-AS is the main inherited type and severe changes of GBM are common in XL-AS males. Proteinuria increases remarkably with age. The detection of type IV collagen in renal tissue or skin is helpful to diagnose Alport syndrome and conifrm inheritance modes.